About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study of rhBMP-2/CPM in Closed Fractures of the Humerus

NCT00384852·37 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Wyeth is now a wholly owned subsidiary of Pfizer

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Skeletally mature subjects age 18 years or older.
Subjects with either a closed proximal humeral fracture or a diaphyseal humeral fracture.
Treatment plan that includes only conservative (nonoperative) therapy within 48 hours following injury.

You may not be if

Shoulder dislocation at the time of injury.
Planned procedure(s) at that would stimulate fracture union at the time of application of the initial immobilization device.
Fractures located in the distal third of humerus.

The record

StatusCompleted

PhasePhase 2

Taking part139

StartedJan 2007

UpdatedFeb 28, 2013

Conditions

Where37

Little Rock, Arkansas, United States
Aurora, Colorado, United States
Denver, Colorado, United States

Clareo Health | A Study of rhBMP-2/CPM in Closed Fractures of the Humerus